Epidemiology of Tuberculosis and HIV Coinfection in the Russian Federation Challenges and Solutions

Size: px
Start display at page:

Download "Epidemiology of Tuberculosis and HIV Coinfection in the Russian Federation Challenges and Solutions"

Transcription

1 LOGO FSBI CTRI RAMN Russian Ministry of Health Epidemiology of Tuberculosis and HIV Coinfection in the Russian Federation Challenges and Solutions I.A.Vasilyeva Chief TD Specialist of the Ministry of Health of the RF Professor, Doctor of Medical Science

2 67th World Health Assembly LOGO POST-2015 GLOBAL TUBERCULOSIS STRATEGY FRAMEWORK VISION GOAL MILESTONES FOR 2025 TARGETS FOR 2035 A world free of tuberculosis zero deaths, disease and suffering due to tuberculosis End the global tuberculosis epidemic 75% reduction in tuberculosis deaths (compared with 2015); 50% reduction in tuberculosis incidence rate (compared with 2015) (less than 55 tuberculosis cases per population) No affected families facing catastrophic costs due to tuberculosis 95% reduction in tuberculosis deaths (compared with 2015) 90% reduction in tuberculosis incidence rate (compared with 2015) (less than 10 tuberculosis cases per population) No affected families facing catastrophic costs due to tuberculosis

3 Thousand Population of RF LOGO Migration Total population in

4 2013 TB incidence and Mortality Rates in the RF (per population) LOGO ,3 52,8 46,4 43,6 48,2 73,9 90,7 83,2 83,5 77,4 73,6 68, ,6 14,1 11,9 34,2 9,7 9,8 7,7 12, , ,7 15,4 12,4 11,3 Заболеваемость Incidence Смертность Mortality Source: Form 8, Rosstat

5 TB Incidence by Federal Districts of the Russian Federation LOGO in 2013 (per population) 140,0 120,0 100,0 115,5 104,7 80,0 77,1 60,0 40,0 63,0 62,7 61,3 47,4 42,7 41,4 20,0 0,0 Source: Form 8

6 40,3 37,9 37,0 36,8 36,7 34,9 34,8 32,4 31,8 29,3 63,0 186,1 177,2 148,4 139,0 138,2 119,2 114,2 110,2 107,9 100,2 TB Incidence by Federal Entities of the Russian Federation LOGO in 2013 (per population) 200,0 180,0 160,0 140,0 120,0 100,0 80,0 60,0 40,0 20,0 0,0 Source: Form 8

7 TB Mortality Rates by Federal Districts of the Russian Federation LOGO in 2013 (per population) 25,0 20,0 21,7 19,2 15,0 14,5 14,1 10,0 11,3 10,1 7,8 6,7 6,1 5,0 0,0 As reported by Rosstat

8 5,1 5,0 4,8 4,1 4,0 3,3 3,0 2,3 2,2 1,9 11,3 34,4 32,8 31,4 27,6 27,5 24,4 24,2 21,5 21,0 59,5 TB Mortality Rates by Federal Entities of the Russian Federation LOGO in 2013 (per population) 70,0 60,0 50,0 40,0 30,0 20,0 10,0 0,0 As reported by Rosstat

9 Percentage of New Pulmonary MDR-TB cases in the RF, LOGO ,4 12,9 14,2 19,4 19,7 15,7 17,1 20,5 19,1 23,7 19,8 22,4 21,1 23, Гражданский Civilian sector сектор Пенитенциарный Penitentiary sector сектор Source: Form 7-TB

10 Percentage of Pulmonary MDR-TB Cases of all Relapse Cases, LOGO ,5 24,8 29,3 34,9 36,8 37,5 33,4 34,7 36, ,1 40,4 37,7 38, Гражданский Civilian sector сектор Пенитенциарный Penitentiary sector сектор Источник: Форма 7-ТБ

11 Countries That Had reported At Least One XDR-TB Case LOGO By the End of 2012 GLOBAL TUBERCULOSIS REPORT 2013

12 Tuberculosis and HIV infection in the World TB is one of the leading causes of death in HIV-infected people worldwide. One fourth of HIVpositive individuals die from TB. About 1/3 of 34 million HIV+ individuals worldwide are infected with TB. HIV infection is the most potent factor causing progression of latent TB infection to active TB disease. IN HIV+ individuals the rates of progression to active TB disease are times higher. Around 10% of people infected with TB actually develop the disease in their lifetimes, in HIVinfected individuals this risk increase up to 5-10% within a year. Global tuberculosis report WHO

13 Incidence of Tuberculosis and HIV-infection in the Russian LOGO Federation (per population) 83,3 82,6 83,3 85,1 82,6 77,2 73,0 68,1 63,0 27,3 29,2 34,7 41,3 43,9 43,8 47,1 52,9 56, год 2006 год 2007 год 2008 год 2009 год 2010 год 2011 год 2012 год 2013 год Tuberculosis Туберкулез HIV-infection ВИЧ-инфекция Source: Forms 8 and 61

14 Prevalence of Tuberculosis and HIV Infection, Russian Federation (per population) LOGO 274,1 281,5 300,1 209,1 203,2 194,7 199,9 222,3 248,1 152,7 153,9 178,5 190,7 185,1 177,5 167,9 157,7 147, год 2006 год 2007 год 2008 год 2009 год 2010 год 2011 год 2012 год 2013 год Tuberculosis Туберкулез HIV-infection ВИЧ-инфекция Source: Form 33 and 61

15 Number of TB/HIV co-infection cases New TB/HIV co-infection cases in the Russian Federation, LOGO 2013 (Including Data from the Penitentiary System since 2007) In 2013, cases of TB/HIV co-infection were detected including those in the penitentiary system выявлено Among civilian среди sector постоянного населения выявлено Among penitentiary во ФСИН sector Source: Form 61

16 Number of TB/HIV co-infection cases Число больных активным туберкулезом в сочетании Number of Notified Active Cases of Tuberculosis and HIV co-infection, (including data from the penitentiary system since 2007) LOGO In 2013, there were HIV/TB notified patients including those in the penitentiary system ТБ-ВИЧ Civilian среди sector постоянного населения ТБ-ВИЧ Penitentiary во ФСИН sector Source: Form 61

17 Distribution of the Number of New HIV/TB Cases by Federal Districts of the Russian Federation in 2013 LOGO 3,60% 2,30% 1,00% RF individuals (100%) 13,50% 7,60% 19,80% 28,60% 23,60% Сибирский Приволжский Уральский Центральный Северо-Западный Южный Дальневосточный Северо-Кавказский Source: Form 33

18 Percentage of New HIV/TB Cases Among All New Notified LOGO TB Cases by Federal Districts, ,2% 15,1% 14,4% 14,3% 12,5% 10,6% 4,7% 3,6% 2,4% Source: Form 33

19 Distribution of Notified HIV/TB Cases by Federal Districts of LOGO the Russian Federation as of 31 December ,8% 2,0% 1,5% RF individuals (100%) 13,0% 8,0% 20,9% 28,7% 21,0% Сибирский Приволжский Уральский Центральный Северо-Западный Южный Дальневосточный Северо-Кавказский Source:Form 33

20 Percentage of HIV/TB Patients among All Notified TB Patients as of December 31, 2013 by Federal Districts of the Russian Federation LOGO 25,0 20,0 20,9 15,0 14,1 13,7 10,0 11,5 10,7 9,2 5,0 4,3 2,8 2,4 0,0 Source: Form 33

21 Number of Notified HIV/TB Patients as of December 31, 2013 LOGO by Federal Districts of the Russian Federation Total patients Source: Form 33

22 Entities of the Russian Federation with the Biggest Number LOGO of Notified HIV/TB Cases as of 31 December Source : Form 33

23 Entities of the Russian Federation with the Lowest Number LOGO of Notified HIV/TB Cases as of 31 December Source : Form 33

24 Number of Patients Who Died From HIV with Manifestations LOGO of Mycobacterial Infection (В 20.0) by Federal Districts in Total 5841 patients died (В20.0) Source: Form 61

25 Ratio of Patients Who Died From TB (А 15-19) and From HIV with Manifestations of Mycobacterial Infection (В 20.0) by Federal Districts in 2013 LOGO 19,7% 38,2% 10,7% 7,4% 32,6% 37,2% 29,1% 7,6% 26,5% 80,3% 61,8% 89,3% 92,6% 67,4% 62,8% 70,9% 92,4% 73,5% ВИЧ/ТБ TB/HIV ТБ TB Sources: Form 61 and Rosstat

26 MDR TB and HIV-Infection LOGO High prevalence of MDR-TB among HIV-infected patients Challenges of MDR-TB diagnostics -low sensitivity of bacteriological methods of mycobacteria detection in HIV-infected individuals (~ 30%) -long time required for common bacteriological methods of detection of MDR mycobacteria ( 2-3 months) -low quality of bacteriological tests In HIV-positive individuals infected with MDR-TB the disease might progress to the lethal form before effective therapy is initiated

27 Characteristics of DR Patterns in Patients with TB and TB/HIV LOGO Depending on the Degree of Immunosuppression TB/HIV CD4<200 35,40% TB/HIV CD4>200 TB 19,2% 20,4% Zimina V.N.,Vasilyeva I.A., 2012

28 Detection of TB in HIV-infected patients LOGO Planned chest X-ray (twice a year) Tuberculin skin test/diaskin-test (once a year) Active By screening of clinical symptoms (cough, fever, sweats, body weight loss) Self-presentation of patients Passive

29 Role of Screening Chest X-Ray Depending on the Degree LOGO of Initial Immunosuppression 27,0% 33,3% 15,8% 7,3% 1,5% 0,8% 73,0% 66,7% 84,2% 92,7% 98,5% 99,2% ТБ CD4>500 СD4: СD4: СD4: CD4<100 ВИЧ/ТБ ВИЧ/ТБ ВИЧ/ТБ ВИЧ/ТБ ВИЧ/ТБ По обращаемости При ФГ Zimina V.N., Kravchenko А.V. Batyrov F.A, 2011

30 Frequency of Positive Mantoux Skin Tests with 2 ТЕ in Patients LOGO with HIV/TB and TB Zimina V.N., Batyrov F.A., 2011 Frequency of Positive Diaskin-Test in patients with HIV/TB and TB Kalinkin A.V. Abstract of the thesis for the degree candidate of med. science 2010

31 LOGO Algorithm for etiological TB diagnostics in HIV-infected patients Diagnostic material (sputum, BAL, liquor, exudate etc.) Rapid detection of MDR-TB MGM Microscopy По Цилю- Нильсену/ Люминесцентная Culture Liquid /solid media DST Priority is given to the rapid diagnostics of DR on liquid media Sputum or any other diagnostic material examination in patients with TB-HIV must include MGM tests to allow detection of an agent and identification of DR at least to rifampicin.

32 LOGO Concept of etiological diagnostics of TB and DR-TB TB detection by means of molecular-genetic and bacteriological methods. DST for all patients: new and previously treated. Introduction of molecular-genetic and rapid methods of culture on liquid media in all regional laboratories. Priority use of molecular-genetic methods for the diagnostics of DR in patients with high risk of MDR- TB and HIV-infected patients.

33 Concept of etiological diagnostics of TB and DR-TB LOGO Access to a comprehensive evaluation of patients regardless of geographical specifics of their places of residence and social status.

34 Procedures for care delivery to TB patients ( Executive order # 932н of November 15, 2012) LOGO REGULATIONS FOR ACTIVITY ARRANGEMENTS TB care unit for HIV-infected patients A unit is to be established for provision of primary specialized care to patients with TB-HIV co-infection.

35 Functions of the unit LOGO Follow-up of patients with TB-HIV co-infection; Management of DOT in patients with TB-HIV co-infection ; Epidemiological analysis of TB HIV co-infection epidemiology in the population of the catchment area; Monitoring and analysis of: Performance of preventive activities among persons with family contacts of TB-HIV patients; Performance of the healthcare facilities in the field of vaccination of children born from mothers with TB including TB-HIV co-infection; Isolation of newborns from mothers with TB including TB-HIV (for 2 months after TB vaccinations); Follow-up of individuals n close family contacts with TB-HIV patients, performance of preventive and health-improving activities for this population group; Provision of managerial, methodological and consultative assistance to the Center for prevention and control of AIDS and infectious diseases in the field of care delivery to patients with TB-HIV co-infection; Managerial and methodological support of TB activities which are being performed among HIV-infected patients; Other functions in accordance with the legislation of the Russian Federation.

36 LOGO TB-HIV prevention activities in the Russian Federation Interaction of TB service and AIDS Centers Preventive TB treatment of patients with HIV-infection TB detection in HIV-infected individuals HIV testing in all TB patients ( in % of all TB patients were tested for HIV) Multidisciplinary approach to management of patients with TB-HIV Treatment of TB-HIV patients based on the general principles of TB treatment considering drug-to -drug interaction

37 Activities on TB detection among HIV-infected LOGO Development and introduction of modern recommendations on TB detection among HIV-infected patients. Training of the medical staff of TB facilities and AIDS centers on modern methods of TB detection and diagnostics in HIVinfected individuals. Training of the medical staff of non-tb facilities on TB detection and diagnostics. Maintaining TB alertness: provision of TB detection and diagnostic algorithms to the district general practitioners and family doctors.

38 In the not-tuberculosis medical organizations LOGO Evaluate TB suspects with the use of rapid moleculargenetic methods of TB and DR-TB detection.

39 Russian Society of Phthisiologists (RSP) LOGO Federal Law No. 323 "On the fundamentals of health protection in the Russian Federation p.2 article 76: «clinical recommendations(protocols) developed and approved by healthcare professional non-commercial organisations»

40 Russian Society of Phthisiologists (RSP) together with the Federal AIDS Center developed LOGO Federal Clinical Recommendations (protocols) for the diagnostics and treatment of TB in HIV-infected individuals

41 LOGO Thank you for your attention!

Strengthening and aligning diagnosis and treatment of drug-resistant TB in Russian Federation

Strengthening and aligning diagnosis and treatment of drug-resistant TB in Russian Federation LOGO Strengthening and aligning diagnosis and treatment of drug-resistant TB in Russian Federation Irina A.Vasilyeva Chief TB Specialist of the Russian Ministry of Health Central TB Research Institute,

More information

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit MODULE SIX Global TB Institutions and Policy Framework Treatment Action Group TB/HIV Advocacy Toolkit 1 Topics to be Covered Global TB policy and coordinating structures The Stop TB Strategy TB/HIV collaborative

More information

Childhood TB: experience of Kazakhstan, national policy and issues of the outpatient treatment

Childhood TB: experience of Kazakhstan, national policy and issues of the outpatient treatment Childhood TB: experience of Kazakhstan, national policy and issues of the outpatient treatment K.S. Serikbayeva National coordinator of childhood TB management Wolfheze, 2013 Republic of Kazakhstan Total

More information

The Barents Tuberculosis Program. The Barents Euro-Arctic Council Joint Working Group on Health and Related Social Issues

The Barents Tuberculosis Program. The Barents Euro-Arctic Council Joint Working Group on Health and Related Social Issues The Barents Tuberculosis Program The Barents Euro-Arctic Council Joint Working Group on Health and Related Social Issues 1 CONTENTS Introduction... 4 General Information... 7 Epidemiological Situation

More information

MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT

MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives Martie van der Walt IOM Meeting 15-17 January 2013 introduction 1 min 150 words

More information

Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite

Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite Riga East Clinical hospital, Centre for tuberculosis and lung diseases. Head of outpatient department.

More information

TB IN EMERGENCIES. Disease Control in Humanitarian Emergencies (DCE)

TB IN EMERGENCIES. Disease Control in Humanitarian Emergencies (DCE) TB IN EMERGENCIES Department of Epidemic and Pandemic Alert and Response (EPR) Health Security and Environment Cluster (HSE) (Acknowledgements WHO Stop TB Programme WHO/STB) 1 Why TB? >33% of the global

More information

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director TB 2015 burden, challenges, response Dr Mario RAVIGLIONE Director Addis Ababa, Ethiopia 11-13 November 2015 Overview TB basics TB burden & challenges Response: End TB Strategy DAY 1 What is TB? Definition

More information

Audit of management of TB in HIV co-infected patients: survey of clinic arrangements

Audit of management of TB in HIV co-infected patients: survey of clinic arrangements Audit of management of TB in HIV co-infected patients: survey of clinic arrangements Please complete this questionnaire if your clinic/department provides TB treatment and care for adult patients, but

More information

Questions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs

Questions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs Questions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs What causes TB? TB is caused by the bacterium Mycobacterium tuberculosis. Although it can cause disease in

More information

Kenya Perspectives. Post-2015 Development Agenda. Tuberculosis

Kenya Perspectives. Post-2015 Development Agenda. Tuberculosis Kenya Perspectives Post-2015 Development Agenda Tuberculosis SPEAKERS Anna Vassall Anna Vassall is Senior Lecturer in Health Economics at the London School of Hygiene and Tropical Medicine. She is a health

More information

Controlling TB in the era of HIV

Controlling TB in the era of HIV Controlling TB in the era of HIV Christy Hanson, PhD, MPH TB Research Advisor Amy Bloom, MD TB/HIV Advisor TB Incidence rates highest in Africa Estimated new TB cases (all forms) per 100 000 population

More information

Problems of MDR-TB in Russia

Problems of MDR-TB in Russia Problems of MDR-TB in Russia Vladislav V. Erokhin Director Central TB Research Institute Russian Academy of Medical Science Tbilisi, September 2007 In 2006: 24055 (20.3%) MDR-TB cases registered in Russia

More information

The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America

The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America Mike Segar / Reuters Executive Summary Context On 26 September 2018, the United Nations

More information

IPT IMPLEMENTATION- SWAZILAND EXPERIENCE

IPT IMPLEMENTATION- SWAZILAND EXPERIENCE IPT IMPLEMENTATION- SWAZILAND EXPERIENCE Gugu Mchunu-National TB/HIV coordinator Programmatic Management of Latent TB infection consultation meeting Seoul, Republic of Korea,27-28 APRIL,2016 TB Epidemiology

More information

TB the basics. (Dr) Margaret (DHA) and John (INZ)

TB the basics. (Dr) Margaret (DHA) and John (INZ) TB the basics (Dr) Margaret (DHA) and John (INZ) Question 1 The scientist who discovered M. tuberculosis was: A: Louis Pasteur B: Robert Koch C: Jean-Antoine Villemin D: Calmette and Guerin Question 2

More information

TOG The Way Forward

TOG The Way Forward TOG 2016- The Way Forward Main Changes in Diagnostic algorithm Definition (Type, Classification, Outcome) Registration at the time of Diagnosis (PHI level Notification Register) Long term follow up (till

More information

New frontiers: Innovation and Access

New frontiers: Innovation and Access 8th Regional TB Symposium Tashkent, Uzbekistan Prof. L.N. Chernousova Central Tuberculosis Research Institute (CTRI) Ministry of Health of the Republic of Uzbekistan 28 February 1 March, 2019 1970 1975

More information

UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME

UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME MINISTRY OF HEALTH UGANDA TIOL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME Revised Strategic Plan 2015/16-2019/20 Monitoring and Evaluation Plan Narrative of the Operational, Budget and Technical Assistance

More information

GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF FEBRUARY 2005] PART I. GROUPED BY AGENCY/ORGANIZATION

GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF FEBRUARY 2005] PART I. GROUPED BY AGENCY/ORGANIZATION GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF FEBRUARY 2005] PART I. GROUPED BY AGENCY/ORGANIZATION Agency/Organization Name of the Guide/Statement Available at World Health Organization 1

More information

TB: INTEGRATION IN HARM REDUCTION PACKAGES. ICF "AIDS Foundation East-West (AFEW Ukraine) Tbilisi, 2015

TB: INTEGRATION IN HARM REDUCTION PACKAGES. ICF AIDS Foundation East-West (AFEW Ukraine) Tbilisi, 2015 TB: INTEGRATION IN HARM REDUCTION PACKAGES ICF "AIDS Foundation East-West (AFEW Ukraine) Tbilisi, 2015 Ʃ = 185 760 «D» 45 083 / 38 126 TB Epidemiology in Ukraine Active TB prevalence in Ukraine (per 100,

More information

Targeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease

Targeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease Self-Study Study Modules on Tuberculosis Targeted Testing and the Diagnosis of Latent Tuberculosis Infection and Tuberculosis Disease 1 Module 3: Objectives At completion of this module, learners will

More information

Tuberculosis and HIV coinfection still a challenge in Central and Eastern Europe

Tuberculosis and HIV coinfection still a challenge in Central and Eastern Europe Tuberculosis and HIV coinfection still a challenge in Central and Eastern Europe Prof. A. Panteleev Pavlov First Saint Petersburg State Medical University 2 nd TB hospital, St. Petersburg 250 200 150

More information

NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 19 April, Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen

NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 19 April, Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 19 April, 2012 Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen Relevance and context of the EG HIV/AIDS & AI work? Necessary to aim

More information

Why is there not enough coordination and collaboration between programmes to implement collaboration TB/HIV activities

Why is there not enough coordination and collaboration between programmes to implement collaboration TB/HIV activities Why is there not enough coordination and collaboration between programmes to implement collaboration TB/HIV activities Olga P. Frolova Head of the TB/HIV Health Care Centre, Ministry of Health Social Development,

More information

GLOBAL TUBERCULOSIS REPORT EXECUTIVE SUMMARY

GLOBAL TUBERCULOSIS REPORT EXECUTIVE SUMMARY GLOBAL TUBERCULOSIS REPORT EXECUTIVE SUMMARY 2018 Context On 26 September 2018, the United Nations (UN) will hold its first highlevel meeting on tuberculosis (TB), at its headquarters in New York. The

More information

Ethiopia. Targeted Tuberculosis Case Finding Interventions in Six Mining Shafts in Remote Districts of Oromia Region in Ethiopia PROJECT CONTEXT

Ethiopia. Targeted Tuberculosis Case Finding Interventions in Six Mining Shafts in Remote Districts of Oromia Region in Ethiopia PROJECT CONTEXT Technical BRIEF Photo Credit: Challenge TB Targeted Tuberculosis Case Finding Interventions in Six Mining Shafts in Remote Districts of Oromia Region in Ethiopia PROJECT CONTEXT Ethiopia is the second-most

More information

GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF NOVEMBER 2004] PART I. GROUPED BY AGENCY/ORGANIZATION

GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF NOVEMBER 2004] PART I. GROUPED BY AGENCY/ORGANIZATION GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF NOVEMBER 2004] PART I. GROUPED BY AGENCY/ORGANIZATION Agency/Organization Name of the Guide/Statement Available at World Health Organization 1

More information

Implementation and scale-up of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB. Global Consultation

Implementation and scale-up of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB. Global Consultation Implementation and scale-up of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB Global Consultation Geneva, 30 November 2010 Mario C. Raviglione, M.D. Director, Stop TB Department WHO, Geneva,

More information

The WHO END-TB Strategy

The WHO END-TB Strategy ENDING TB and MDR-TB The WHO END-TB Strategy Dr Mario RAVIGLIONE Director Joint GDI/GLI Partners Forum WHO Geneva, 27 April 2015 This talk will deal with TB Burden Progress, Challenges Way Forward Who

More information

Fundamentals of Tuberculosis (TB)

Fundamentals of Tuberculosis (TB) TB in the United States Fundamentals of Tuberculosis (TB) From 1953 to 1984, reported cases decreased by approximately 5.6% each year From 1985 to 1992, reported cases increased by 20% 25,313 cases reported

More information

New NICE guideline updates recommendations for diagnosing latent tuberculosis

New NICE guideline updates recommendations for diagnosing latent tuberculosis Tel: 0845 003 7782 www.nice.org.uk Ref: 2011/053 PRESS RELEASE New NICE guideline updates recommendations for diagnosing latent tuberculosis The National Institute for Health and Clinical Excellence (NICE)

More information

NHS SHETLAND TUBERCULOSIS ANNUAL REPORT

NHS SHETLAND TUBERCULOSIS ANNUAL REPORT NHS SHETLAND TUBERCULOSIS ANNUAL REPORT 2014-2015 Prepared by Wendy Hatrick October 2015 NHS Shetland Tuberculosis Annual Report 2013-14 Acronyms and Abbreviations AIDS Acquired Immuno-Deficiency Syndrome

More information

Global, National, Regional

Global, National, Regional Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology

More information

(13) "Pulmonary tuberculosis" means tuberculosis that affects the lungs.

(13) Pulmonary tuberculosis means tuberculosis that affects the lungs. ACTION: Withdraw Final DATE: 12/06/2005 8:17 AM 5122-3-09 Integrated behavioral healthcare system (IBHS) tuberculosis control program. (A) The purpose of this rule shall be to establish a policy that will

More information

11/3/2009 SECOND EDITION Madhukar Pai McGill University. ISTC Training Modules Introduction

11/3/2009 SECOND EDITION Madhukar Pai McGill University. ISTC Training Modules Introduction SECOND EDITION 2009 Madhukar Pai McGill University Introduction 1 Purpose of ISTC ISTC Version 2: Key Points 21 Standards Differ from existing guidelines: standards present what should be done, whereas,

More information

INDEX CASE INFORMATION

INDEX CASE INFORMATION Instructions for Completing the MDH Tuberculosis Contact Investigation Report Form Please provide as much information as possible. Each field represents information that is important to the contact investigation.

More information

TB/HIV management survey

TB/HIV management survey TB/HIV management survey! Baseline audit in parallel with guidelines development process! Survey of clinician opinion and practice! Data collection from October 2004 to January 2005! Data was received

More information

Modern TB Diagnostic Services: Optimizing the Old with the New

Modern TB Diagnostic Services: Optimizing the Old with the New Modern TB Diagnostic Services: Optimizing the Old with the New 6 th Global Laboratory Initiative (GLI) Partners Meeting incorporating Global consultation of the TB SRL Network Global Forum of Xpert MTB/RIF

More information

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB February 2017 Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB 1. Background TB is the leading cause of death by infectious disease, killing 1.8 million people in 2015. Each

More information

Scaling up collaborative TB/HIV activities: achievements, challenges, and opportunities in Viet Nam

Scaling up collaborative TB/HIV activities: achievements, challenges, and opportunities in Viet Nam Scaling up collaborative TB/HIV activities: achievements, challenges, and opportunities in Viet Nam 20 th International AIDS Conference, 20 July 2014, Melbourne, Australia Nguyen Hoang Long, MD, Ph.D.

More information

HIV Clinicians Society Conference TB/HIV Treatment Cascade

HIV Clinicians Society Conference TB/HIV Treatment Cascade HIV Clinicians Society Conference-2012 TB/HIV Treatment Cascade Dr Judith Mwansa-Kambafwile Wits Reproductive Health & HIV Institute University of Witwatersrand TB/HIV Treatment Cascade Overview TB stats

More information

Latent Tuberculosis Infection (LTBI) Questions and Answers for Health Care Providers

Latent Tuberculosis Infection (LTBI) Questions and Answers for Health Care Providers Latent Tuberculosis Infection (LTBI) Questions and Answers for Health Care Providers Who Should Be Screened for Latent Tuberculosis Infection (LTBI)?... 2 What tests are used to screen for LTBI?... 2 How

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Tuberculosis: interferon gamma tests for the diagnosis of latent tuberculosis (partial update) 1.1 Short title Tuberculosis

More information

The New WHO guidelines on intensified TB case finding and Isoniazid preventive therapy and operational considerations

The New WHO guidelines on intensified TB case finding and Isoniazid preventive therapy and operational considerations Workshop to accelerate the implementation of the Three Is for HIV/TB and earlier initiation of ART in Southern Africa, March 14-18, 2011, Johannesburg, South Africa. The New WHO guidelines on intensified

More information

CHAPTER:1 TUBERCULOSIS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

CHAPTER:1 TUBERCULOSIS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY CHAPTER:1 TUBERCULOSIS BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY GLOBAL EMERGENCY: * Tuberculosis kills 5,000 people a day! * 2.3 million die each year!

More information

Xpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection. Results of Group Work

Xpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection. Results of Group Work Xpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection Results of Group Work DOTS expansion and enhancement Objective This group deals with the majority

More information

Appendix B. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)

Appendix B. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Appendix B Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Since publication of the Recommendations for Counting Reported Tuberculosis Cases 1 in January 1977, numerous changes

More information

Childhood Tuberculosis Some Basic Issues. Jeffrey R. Starke, M.D. Baylor College of Medicine

Childhood Tuberculosis Some Basic Issues. Jeffrey R. Starke, M.D. Baylor College of Medicine Childhood Tuberculosis Some Basic Issues Jeffrey R. Starke, M.D. Baylor College of Medicine TUBERCULOSIS IS A SOCIAL DISEASE WITH MEDICAL IMPLICATIONS THE GREAT PARADOX OF TUBERCULOSIS A CAUTIONARY TALE

More information

SURVEY FINDINGS April 28, 2017

SURVEY FINDINGS April 28, 2017 SURVEY FINDINGS April 28, 2017 Brenda Mungai Centre for Health Solutions-Kenya, TB ARC Outline Background Survey Rationale Methods Key Findings Conclusions Call to Action KENYA TUBERCULOSIS PREVALENCE

More information

TB and Respiratory Protection

TB and Respiratory Protection Slide 1 TB and Respiratory Protection Tuberculosis (TB) is a disease present throughout the United States. Lehigh Valley Health Network is concerned about your health and needs your help to prevent the

More information

Arizona Annual Tuberculosis Surveillance Report

Arizona Annual Tuberculosis Surveillance Report Arizona Annual Tuberculosis Surveillance Report 2014 Table of Contents I. Executive Summary 1 II. Case Rates 3 III. Cases and Case Rates by Race and Ethnicity 4 IV. Cases by Gender 4 V. Cases and Case

More information

TB: A Supplement to GP CLINICS

TB: A Supplement to GP CLINICS TB: A Supplement to GP CLINICS Chapter 10: Childhood Tuberculosis: Q&A For Primary Care Physicians Author: Madhukar Pai, MD, PhD Author and Series Editor What is Childhood TB and who is at risk? India

More information

New Tuberculosis Guidelines. Jason Stout, MD, MHS

New Tuberculosis Guidelines. Jason Stout, MD, MHS New Tuberculosis Guidelines Jason Stout, MD, MHS Two New Sets of Guidelines Treatment of Drug-Susceptible Tuberculosis Clinical Infectious Diseases 2016; 63(7): e147-e195 Diagnosis of Tuberculosis in Adults

More information

2017/2018 Annual Volunteer Tuberculosis Notice

2017/2018 Annual Volunteer Tuberculosis Notice Lewis Center for Educational Research Academy for Academic Excellence Norton Science and Language Academy Business Offices 17500 Mana Road Apple Valley, CA 92307 E-mail: hr@lcer.org 760-946-5414 Fax 760-946-9193

More information

Revised National Tuberculosis Control Programme

Revised National Tuberculosis Control Programme Revised National Tuberculosis Control Programme 1 OUTLINE OF PRESENTATION Introduction Burden Of The Disease Evolution Of RNTCP Goals And Objectives Of RNTCP DOTS Stop TB Strategy Organization RNTCP Endorsed

More information

TB Program and Epidemic aka B2B

TB Program and Epidemic aka B2B TB Program and Epidemic aka B2B Nulda Beyers On behalf of DTTC BOD Workshop 30 September2013 Trend in tuberculosis incidence, selected countries in Africa 1400 1200 Rate per 100,000 1000 800 600 400 200

More information

Appendix C. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)

Appendix C. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Appendix C Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Since publication of the Recommendations for Counting Reported Tuberculosis Cases 1 in January 1977, numerous changes

More information

Diagnosis of HIV and TB in the Finnish primary health care. Pekka Suomalainen M.D

Diagnosis of HIV and TB in the Finnish primary health care. Pekka Suomalainen M.D Diagnosis of HIV and TB in the Finnish primary health care Inter-regional international conference Early diagnosis of HIV and associated infections, including TB, in the primary healthcare sector Petrozavodsk

More information

Tuberculosis Procedure ICPr016. Table of Contents

Tuberculosis Procedure ICPr016. Table of Contents Tuberculosis Procedure ICPr016 Table of Contents Tuberculosis Procedure ICPr016... 1 What is Tuberculosis?... 2 Any required definitions/explanations... 2 NHFT... 2 Tuberculosis (TB)... 3 Latent TB...

More information

Northwestern Polytechnic University

Northwestern Polytechnic University Clinical Tuberculosis Assessment by Health Care Provider Clinicians should review and verify the information in the Tuberculosis (TB) Screening Questionnaire (attached). Persons answering YES to any questions

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE TB Partial Update Appendix 1 - Scope NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Tuberculosis: interferon gamma tests for the diagnosis of latent tuberculosis (partial

More information

Ministry of Health. National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015)

Ministry of Health. National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015) Ministry of Health National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015) Contents Executive summary... 2 Background... 3 National Tuberculosis Program Overview... 3

More information

(a) Infection control program. The facility must establish an infection control program under which it--

(a) Infection control program. The facility must establish an infection control program under which it-- 420-5-10-.17 Infection Control. (1) The facility must establish and maintain an infection control program designed to provide a safe, sanitary, and comfortable environment and to help prevent the development

More information

Interventions to improve screening for latent TB: effectiveness and outcomes

Interventions to improve screening for latent TB: effectiveness and outcomes Interventions to improve screening for latent TB: effectiveness and outcomes Fotinie Ntziora, Thushan DeSilva, Natasha Baker, Debbie Talbot, Louise Byrne, Karen Sherry, Sandra Booth, Janice Hobson, Karen

More information

Costing of the Sierra Leone National Strategic Plan for TB

Costing of the Sierra Leone National Strategic Plan for TB Costing of the Sierra Leone National Strategic Plan for TB 2016-2020 Introduction The Government of Sierra Leone established the National Leprosy Control Programme in 1973 with support from the German

More information

Active case finding. Care Pathways: Seek Find Follow

Active case finding. Care Pathways: Seek Find Follow Active case finding Care Pathways: Seek Find Follow Overview The HIV/AIDS epidemic in Cape Winelands The NSP indicators Care pathways Historical perspective of case finding: TB Historical perspective of

More information

Stop TB Poster (laminated copies are available from TB Control: )

Stop TB Poster (laminated copies are available from TB Control: ) Tuberculosis Prevention and Control Recommendations For Homeless Shelters in Maine Tool Kit What Your Shelter Can Do to Prevent TB Assessing Your Shelter Guests Risk for TB Cough Alert Policy Think TB

More information

Tuberculosis & Refugees in Philadelphia

Tuberculosis & Refugees in Philadelphia Tuberculosis & Refugees in Philadelphia Philadelphia TB Control Program Daniel P. Dohony, MPH Philadelphia TB Control Program Health Information Portal Website: hip.phila.gov Contains Information On» Disease

More information

Tuberculosis in NSW,

Tuberculosis in NSW, EPIREVIEW Tuberculosis in NSW, 2003 2007 Bridget A. O Connor, Lindy L. Fritsche, Amanda J. Christensen and Jeremy M. McAnulty Communicable Diseases Branch, NSW Department of Health Tuberculosis (TB) has

More information

VERSION STUDENT. Outbreak of Tuberculosis in a Homeless Men s Shelter. Cases in Population-Oriented Prevention (C-POP)-based teaching cases

VERSION STUDENT. Outbreak of Tuberculosis in a Homeless Men s Shelter. Cases in Population-Oriented Prevention (C-POP)-based teaching cases STUDENT VERSION This project has the objective to develop preventive medicine teaching cases that will motivate medical students, residents and faculty to improve clinical preventive competencies complemented

More information

Let s Talk TB. A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year

Let s Talk TB. A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year Lancelot M. Pinto, MD, MSc Author Madhukar Pai, MD, PhD co-author and Series Editor Abstract Nearly 50% of patients with

More information

Global, National, Regional

Global, National, Regional Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology

More information

Epidemiology and diagnosis of MDR-TB in children H Simon Schaaf

Epidemiology and diagnosis of MDR-TB in children H Simon Schaaf Epidemiology and diagnosis of MDR-TB in children H Simon Schaaf Desmond Tutu TB Centre Department of Paediatrics and Child Health, Stellenbosch University, and Tygerberg Children s Hospital (TCH) Definitions

More information

Definitions and reporting framework for tuberculosis 2013 revision. Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013

Definitions and reporting framework for tuberculosis 2013 revision. Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013 Definitions and reporting framework for tuberculosis 2013 revision Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013 2-year revision process WHO/HTM/TB/2013.2 2 www.who.int/iris/bitstream/10665/79199/1/9789241505345_eng.pdf

More information

Revised National Tuberculosis Control Programme (RNTCP) Dr.Kishore Yadav J Assistant Professor

Revised National Tuberculosis Control Programme (RNTCP) Dr.Kishore Yadav J Assistant Professor Revised National Tuberculosis Control Programme (RNTCP) Dr.Kishore Yadav J Assistant Professor Global scenario*: Burden of TB Incidence : 9.6 million (58% SEAR and Western Pacific) Deaths : 1.5 million

More information

What is tuberculosis? What causes tuberculosis?

What is tuberculosis? What causes tuberculosis? What is tuberculosis? What causes tuberculosis? Last updated: Thursday 4 September 2014 Tuberculosis Infectious Diseases / Bacteria / Viruses Respiratory / Asthma Some may see Tuberculosis as a historical

More information

INTRODUCTION AND GUIDING PRINCIPLES

INTRODUCTION AND GUIDING PRINCIPLES CHAPTER 1 INTRODUCTION AND GUIDING PRINCIPLES The Operations Manual is intended for use in countries with high HIV prevalence and provides operational guidance on delivering HIV services at health centres.

More information

Interferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines

Interferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines Interferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines Historically, Latent Tuberculosis Infection (LTBI) diagnosis was based on risk assessment, chest x-ray (CXR)

More information

All you need to know about Tuberculosis

All you need to know about Tuberculosis All you need to know about Tuberculosis What is tuberculosis? Tuberculosis is an infectious disease that usually affects the lungs. Doctors make a distinction between two kinds of tuberculosis infection:

More information

5. HIV-positive individuals treated with INH should receive Pyridoxine (B6) 25 mg daily or 50 mg twice/thrice weekly on the same schedule as INH

5. HIV-positive individuals treated with INH should receive Pyridoxine (B6) 25 mg daily or 50 mg twice/thrice weekly on the same schedule as INH V. TB and HIV/AIDS A. Standards of Treatment and Management The majority of TB treatment principles apply to persons with HIV/AIDS who require treatment for TB disease. The following points are either

More information

Principle of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos

Principle of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos Principle of Tuberculosis Control CHIANG Chen-Yuan MD, MPH, DrPhilos Estimated global tuberculosis burden 2015 an estimated 10.4 million incident cases of TB (range, 8.7 million 12.2 million) 142 cases

More information

International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007

International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007 TB Along the US/Mexico Border El Paso, Texas August 22-23, 2007 International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007 Barbara J Seaworth MD Medical Director Heartland National

More information

ADDRESSING MDR TB IN THE CONTEXT OF HIV: Lessons from Lesotho. Dr Hind Satti PIH Lesotho Director MDR-TB program

ADDRESSING MDR TB IN THE CONTEXT OF HIV: Lessons from Lesotho. Dr Hind Satti PIH Lesotho Director MDR-TB program ADDRESSING MDR TB IN THE CONTEXT OF HIV: Lessons from Lesotho Dr Hind Satti PIH Lesotho Director MDR-TB program TB Situation in Lesotho 12,275 TB new cases notified in 2007 Estimated prevalence of 544

More information

The Western Pacific Region faces significant

The Western Pacific Region faces significant COMBATING COMMUNICABLE DISEASES A medical technician draws blood for HIV screening in Manila. AFP elimination of mother-to-child transmission of HIV and congenital syphilis was piloted in Malaysia and

More information

COHORT STUDY OF HIV POSITIVE AND HIV NEGATIVE TUBERCULOSIS in PENANG HOSPITAL: COMPARISON OF CLINICAL MANIFESTATIONS

COHORT STUDY OF HIV POSITIVE AND HIV NEGATIVE TUBERCULOSIS in PENANG HOSPITAL: COMPARISON OF CLINICAL MANIFESTATIONS COHORT STUDY OF HIV POSITIVE AND HIV NEGATIVE TUBERCULOSIS in PENANG HOSPITAL: COMPARISON OF CLINICAL MANIFESTATIONS Ong CK 1, Tan WC 2, Leong KN 2, Abdul Razak M 1, Chow TS 2 1 Respiratory Unit, Penang

More information

World Health Organization HIV/TB Facts 2011

World Health Organization HIV/TB Facts 2011 World Health Organization HIV/TB Facts 20 Note: The facts and figures of the HIV/TB Facts 20 are drawn from WHO HIV and TB surveillance data from 200 and 2009, as referenced below. Why is tuberculosis

More information

Cost-effectiveness of ART and the Three I s for HIV/TB to prevent tuberculosis

Cost-effectiveness of ART and the Three I s for HIV/TB to prevent tuberculosis Cost-effectiveness of ART and the Three I s for HIV/TB to prevent tuberculosis among people living with HIV Somya Gupta, Taiwo Abimbola, Anand Date, Amitabh B. Suthar, Rod Bennett, Nalinee Sangrujee, Reuben

More information

INTENSIFIED TB CASE FINDING

INTENSIFIED TB CASE FINDING INTENSIFIED TB CASE FINDING My friends call me Intensified Case Finding (ICF) I undertake regularly screening all people with, or at high risk of HIV, for symptoms of TB in health care facilities, communities

More information

Communicable Disease Control Manual Chapter 4: Tuberculosis

Communicable Disease Control Manual Chapter 4: Tuberculosis Provincial TB Services 655 West 12th Avenue Vancouver, BC V5Z 4R4 www.bccdc.ca Communicable Disease Control Manual Definitions Page 1 2.0 DEFINITIONS Many of the definitions that follow are taken from

More information

Overview of the Presentation

Overview of the Presentation Overview of the Presentation Definitions(TBCase, MDR-TB & XDR-TB) Global Tuberculosis (TB,HIV/TB,MDR & XDR)Scenario & Trend Risk factor for TB Natural history of TB Types of TB & Trends of Extra Pulmonary

More information

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director. 30 August 2007 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-seventh session Brazzaville, Republic of Congo, 27 31 August Provisional agenda item 7.8 TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE

More information

Xpert MTB/RIF test Rollout and Implementation Plan

Xpert MTB/RIF test Rollout and Implementation Plan Xpert MTB/RIF test Rollout and Implementation Plan UNITED REPUBLIC OF TANZANIA MINISTRY OF HEALTH AND SOCIAL WELFARE NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME 6 Samora Machel Avenue P.O. Box 9083 11478

More information

LATENT TUBERCULOSIS. Robert F. Tyree, MD

LATENT TUBERCULOSIS. Robert F. Tyree, MD LATENT TUBERCULOSIS Robert F. Tyree, MD 1 YK TB OFFICERS Ron Bowerman Elizabeth Roll Mien Chyi (Pediatrics) Cindi Mondesir (Pediatrics) The new guys: Philip Johnson Robert Tyree 2009 CDC TB CASE DEFINITION

More information

Vice Chancellor, Health Affairs & Dean, School of Medicine Vice Chancellor & Dean s Office Origination Date: 05/20/2013 Date of Revision: Scope:

Vice Chancellor, Health Affairs & Dean, School of Medicine Vice Chancellor & Dean s Office Origination Date: 05/20/2013 Date of Revision: Scope: UC Riverside, School of Medicine Policies and Procedures Policy Title: Vaccination and Immunization Requirements Policy Number: SOM 4.0 Responsible Officer: Responsible Office: Vice Chancellor, Health

More information

CMH Working Paper Series

CMH Working Paper Series CMH Working Paper Series Paper No. WG5 : 8 Title Interventions to reduce tuberculosis mortality and transmission in low and middle-income countries: effectiveness, cost-effectiveness, and constraints to

More information

COFM Immunization Policy

COFM Immunization Policy COUNCIL OF ONTARIO FACULTIES OF MEDICINE An affiliate of the Council of Ontario Universities COFM Immunization Policy This policy applies to all undergraduate medical students attending an Ontario medical

More information

Appendix B. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)

Appendix B. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Appendix B Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Since publication of the Recommendations for Counting Reported Tuberculosis Cases 1 in January 1977, numerous changes

More information

ANALYSIS AND USE OF HEALTH FACILITY DATA. Guidance for tuberculosis programme managers

ANALYSIS AND USE OF HEALTH FACILITY DATA. Guidance for tuberculosis programme managers ANALYSIS AND USE OF HEALTH FACILITY DATA Guidance for tuberculosis programme managers WORKING DOCUMENT SEPTEMBER 2018 World Health Organization 2018 All rights reserved. This is a working document and

More information

TB in the Patient with HIV

TB in the Patient with HIV TB in the Patient with HIV Lisa Y. Armitige, MD, PhD May 11, 2017 TB Intensive May 9 12, 2017 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD, has the following disclosures to

More information